These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32371911)

  • 1. Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis.
    McDonald K; Glezeva N; Collier P; O'Reilly J; O'Connell E; Tea I; Russell-Hallinan A; Tonry C; Pennington S; Gallagher J; Ledwidge M; Baugh J; Watson CJ
    Sci Rep; 2020 May; 10(1):7507. PubMed ID: 32371911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure.
    Watson CJ; Ledwidge MT; Phelan D; Collier P; Byrne JC; Dunn MJ; McDonald KM; Baugh JA
    Circ Heart Fail; 2011 Mar; 4(2):188-97. PubMed ID: 21282491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
    Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
    J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure.
    Andersen IA; Huntley BK; Sandberg SS; Heublein DM; Burnett JC
    Nephrol Dial Transplant; 2016 May; 31(5):767-72. PubMed ID: 26666498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL.
    Oikonomou E; Tsalamandris S; Karlis D; Siasos G; Chrysohoou C; Vogiatzi G; Dimitropoulos S; Charalambous G; Kouskouni E; Tousoulis D
    Biomark Med; 2018 Dec; 12(12):1323-1330. PubMed ID: 30511581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure.
    Yin WH; Wei J; Huang WP; Chen JW; Young MS; Lin SJ
    Circ J; 2012; 76(9):2139-47. PubMed ID: 22785032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse changes in plasma tetranectin and titin levels in patients with type 2 diabetes mellitus: a potential predictor of acute myocardial infarction?
    Rahim MAA; Rahim ZHA; Ahmad WAW; Bakri MM; Ismail MD; Hashim OH
    Acta Pharmacol Sin; 2018 Jul; 39(7):1197-1207. PubMed ID: 29417940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.
    Wells QS; Gupta DK; Smith JG; Collins SP; Storrow AB; Ferguson J; Smith ML; Pulley JM; Collier S; Wang X; Roden DM; Gerszten RE; Wang TJ
    J Am Coll Cardiol; 2019 May; 73(17):2195-2205. PubMed ID: 31047008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure.
    Liu W; Zheng J; Dong J; Bai R; Song D; Ma X; Zhao L; Yao Y; Zhang H; Liu T
    Cardiology; 2018; 141(4):212-225. PubMed ID: 30836355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.
    Lin X; Zhang S; Huo Z
    Int Heart J; 2019 Mar; 60(2):280-286. PubMed ID: 30745540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of pancreatitis-associated protein, a novel biomarker, to predict severity of disease in ambulatory patients with heart failure.
    Fitzgibbons TP; Paolino J; Dagorn JC; Meyer TE
    Am J Cardiol; 2014 Jan; 113(1):123-6. PubMed ID: 24188888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study.
    Barasch E; Gottdiener JS; Aurigemma G; Kitzman DW; Han J; Kop WJ; Tracy RP
    Circ Heart Fail; 2009 Jul; 2(4):303-10. PubMed ID: 19808353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
    Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
    J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    Wong LL; Zou R; Zhou L; Lim JY; Phua DCY; Liu C; Chong JPC; Ng JYX; Liew OW; Chan SP; Chen YT; Chan MMY; Yeo PSD; Ng TP; Ling LH; Sim D; Leong KTG; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lund M; Devlin G; Troughton R; Cameron VA; Doughty RN; Lam CSP; Too HP; Richards AM
    J Am Coll Cardiol; 2019 Mar; 73(11):1300-1313. PubMed ID: 30898206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetranectin as a potential novel prognostic biomarker in anthracycline-related cardiac dysfunction.
    Kopeva KV; Grakova EV; Shilov SN; Berezikova EN; Bobyleva ET; Teplyakov AT
    Heart Vessels; 2023 Oct; 38(10):1256-1266. PubMed ID: 37310463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.